Related Experiment Video
Updated: Jun 26, 2026

Quantitative Fundus Autofluorescence for the Evaluation of Retinal Diseases
Published on: March 11, 2016
A novel bilateral cross-attention network for multi-label fundus disease diagnosis
Yang Zhou1, Qiaolu Wang1, Hua Zhong1
1School of Artificial intelligence and Electronic engineering, Sichuan Technology and Business University, No. 65, Xueyuan road, Pidu District, Chengdu, Sichuan, 611745, China.
Abstract:
Multi-label fundus disease classification aims to assign multiple ocular disease labels to bilateral fundus images, enabling automated screening and clinical decision support. In contrast to most existing computer-aided systems that process each eye independently and rely on shallow feature fusion, we explicitly model binocular structure and adaptively combine information from both eyes to handle complex, real-world fundus scenes. To this end, we introduce DualCrossAttnNet, a multi-label fundus disease classification network specifically designed for binocular analysis. In particular, we obtain high-resolution bilateral representations using an EfficientNet-B2 backbone and a cross-attention module that jointly reasons about spatial and channel-wise interactions between the left and right eyes. We further employ a gated fusion mechanism to adaptively weight the contributions of each eye, and an SE attention module to recalibrate channel responses before global aggregation. Coupled with a fundus-oriented preprocessing pipeline and a GeM-based classifier, the proposed framework can accurately predict multiple co-occurring ocular diseases from complex clinical fundus images. On the public ODIR-2019 dataset, DualCrossAttnNet substantially improves multi-label classification performance, achieving 88.20% accuracy, 90.98% F1, and 98.49% AUC, with a composite score of 92.73%. These results surpass recent CNN, GNN, and Transformer-based baselines by up to 20.37 percentage points in composite score, demonstrating that DualCrossAttnNet is an effective and scalable solution for intelligent fundus disease diagnosis.
